Solvay Pharma India Ltd has informed that the members at the Annual General Meeting (AGM) of the Company held on April 25, 2008, inter alia, have passed the following resolutions:
1. Adoption of the Audited Balance Sheet as at December 31, 2007 and the Profit & Loss Account for the year ended on that date and the Directors and Auditors Report thereon.
2. Declaration of interim dividend of Rs 25 /- per share paid during the year, Final Dividend, for the year ended December 31, 2007, of Rs 15/- (150%) per share.
3. Re-appointment of Mr. M S Grewal & Dr. Dominique Baum, as Directors of the Company.
4. Appointment of Messrs. Deloitte Haskins & Sells, Chartered Accountants, as Auditors of the Company to hold office from the conclusion of this meeting until the conclusion of the next Annual General Meeting of the Company, on remuneration, terms & conditions.
5. Re-appointment of Dr. Dominique Baum as the Managing Director of the Company from November 01, 2007 for a period of two years, on remuneration, terms & conditions.
1. Adoption of the Audited Balance Sheet as at December 31, 2007 and the Profit & Loss Account for the year ended on that date and the Directors and Auditors Report thereon.
2. Declaration of interim dividend of Rs 25 /- per share paid during the year, Final Dividend, for the year ended December 31, 2007, of Rs 15/- (150%) per share.
3. Re-appointment of Mr. M S Grewal & Dr. Dominique Baum, as Directors of the Company.
4. Appointment of Messrs. Deloitte Haskins & Sells, Chartered Accountants, as Auditors of the Company to hold office from the conclusion of this meeting until the conclusion of the next Annual General Meeting of the Company, on remuneration, terms & conditions.
5. Re-appointment of Dr. Dominique Baum as the Managing Director of the Company from November 01, 2007 for a period of two years, on remuneration, terms & conditions.
No comments:
Post a Comment